An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples